Adalimumab for moderate to severe chronic plaque psoriasis

Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy.

Papp K, Crowley J, Ortonne JP, Leu J, Okun M, Gupta SR, Gu Y, Langley RG.

Probity Medical Research, Waterloo, Ontario, Canada Bakersfield Dermatology, Bakersfield, California, United States Nice University Hospital, Nice, France Abbott Laboratories, Abbott Park, Illinois, United States Dalhousie University, Halifax, Nova Scotia.

Read more...

Combination of Oral Corticosteroids and Polidocanol Sclerotherapy in the Management of Infantile Hemangiomas

Grover C, Arora P, Kedar A, Pal P, Lal B.

Department of Dermatology, Chacha Nehru Bal Chikitsalaya, New Delhi, India.

Read more...

Depigmentation therapies for normal skin in vitiligo universalis

Alghamdi K, Kumar A.

Dermatology Department Vitiligo Research Chair, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Read more...

Allergic Diseases in Pregnancy: Overview of Diagnosis and therapy

[Article in German]

Treudler R.

Klinik für Dermatologie, Venerologie und Allergologie, Universität Leipzig, Philipp-Rosenthal-Str. 23, 04103, Leipzig, Deutschland, This email address is being protected from spambots. You need JavaScript enabled to view it. .

Read more...